JUST IN
You are here: Home » News-CM » Companies » News

RBI makes changes in NEFT, RTGS for daily reporting of foreign remittances

Zydus receives USFDA approval for Sirolimus Tablets
Business Standard

Lupin receives Establishment Inspection Report for its new injectable unit in Nagpur

Capital Market 

Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its new injectable facility located in Nagpur, India.

The EIR was issued post the last inspection of the facility conducted from 17 October 2022 to 29 October 2022.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Fri, February 17 2023. 10:14 IST

PREVIOUS STORY

NEXT STORY
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU